Literature DB >> 11043767

Targets of B-cell antigen receptor signaling: the phosphatidylinositol 3-kinase/Akt/glycogen synthase kinase-3 signaling pathway and the Rap1 GTPase.

M R Gold1, R J Ingham, S J McLeod, S L Christian, M P Scheid, V Duronio, L Santos, L Matsuuchi.   

Abstract

In this review, we discuss the role of phosphatidylinositol 3-kinase (PI3K) and Rap 1 in B-cell receptor (BCR) signaling. PI3K produces lipids that recruit pleckstrin homology domain-containing proteins to the plasma membrane. Akt is a kinase that the BCR activates in this manner. Akt phosphorylates several transcription factors as well as proteins that regulate apoptosis and protein synthesis. Akt also regulates glycogen synthase kinase-3, a kinase whose substrates include the nuclear factor of activated T cells (NF-AT)cl and beta-catenin transcriptional activators. In addition to Akt, PI3K-derived lipids also regulate the activity and localization of other targets of BCR signaling. Thus, a key event in BCR signaling is the recruitment of PI3K to the plasma membrane where its substrates are located. This is mediated by binding of the Src homology (SH) 2 domains in PI3K to phosphotyrosine-containing sequences on membrane-associated docking proteins. The docking proteins that the BCR uses to recruit PI3K include CD19, Cbl, Gab1, and perhaps Gab2. We have shown that Gab1 colocalizes PI3K with SH2 domain-containing inositol phosphatase (SHIP) and SHP2, two enzymes that regulate PI3K-dependent signaling. In contrast to PI3K, little is known about the Rap1 GTPase. We showed that the BCR activates Rap1 via phospholipase C-dependent production of diacylglycerol. Since Rap1 is thought to regulate cell adhesion and cell polarity, it may be involved in B-cell migration.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11043767     DOI: 10.1034/j.1600-065x.2000.00601.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  15 in total

Review 1.  The B-cell receptor signaling pathway as a therapeutic target in CLL.

Authors:  Jennifer A Woyach; Amy J Johnson; John C Byrd
Journal:  Blood       Date:  2012-06-19       Impact factor: 22.113

2.  Pivotal advance: CEACAM1 is a negative coreceptor for the B cell receptor and promotes CD19-mediated adhesion of B cells in a PI3K-dependent manner.

Authors:  Elizabeth O Lobo; Zhifang Zhang; John E Shively
Journal:  J Leukoc Biol       Date:  2009-05-19       Impact factor: 4.962

3.  Identification of predictive markers of cytarabine response in AML by integrative analysis of gene-expression profiles with multiple phenotypes.

Authors:  Jatinder K Lamba; Kristine R Crews; Stanley B Pounds; Xueyuan Cao; Varsha Gandhi; William Plunkett; Bassem I Razzouk; Vishal Lamba; Sharyn D Baker; Susana C Raimondi; Dario Campana; Ching-Hon Pui; James R Downing; Jeffrey E Rubnitz; Raul C Ribeiro
Journal:  Pharmacogenomics       Date:  2011-03       Impact factor: 2.533

Review 4.  Chronic Lymphocytic Leukemia: Exploiting Vulnerabilities with Targeted Agents.

Authors:  Joseph Maly; James S Blachly
Journal:  Curr Hematol Malig Rep       Date:  2016-02       Impact factor: 3.952

5.  Glucose-induced Akt1 activation mediates fibronectin synthesis in endothelial cells.

Authors:  X Xin; Z A Khan; S Chen; S Chakrabarti
Journal:  Diabetologia       Date:  2005-09-29       Impact factor: 10.122

6.  CD19 is a major B cell receptor-independent activator of MYC-driven B-lymphomagenesis.

Authors:  Elaine Y Chung; James N Psathas; Duonan Yu; Yimei Li; Mitchell J Weiss; Andrei Thomas-Tikhonenko
Journal:  J Clin Invest       Date:  2012-05-01       Impact factor: 14.808

7.  Function, regulation and pathological roles of the Gab/DOS docking proteins.

Authors:  Franziska U Wöhrle; Roger J Daly; Tilman Brummer
Journal:  Cell Commun Signal       Date:  2009-09-08       Impact factor: 5.712

8.  Idelalisib Impacts Cell Growth through Inhibiting Translation-Regulatory Mechanisms in Mantle Cell Lymphoma.

Authors:  Qingshan Yang; Lisa S Chen; Min Jin Ha; Kim-Anh Do; Sattva S Neelapu; Varsha Gandhi
Journal:  Clin Cancer Res       Date:  2016-06-24       Impact factor: 12.531

9.  Digital gene expression profiling of primary acute lymphoblastic leukemia cells.

Authors:  J Nordlund; A Kiialainen; O Karlberg; E C Berglund; H Göransson-Kultima; M Sønderkær; K L Nielsen; M G Gustafsson; M Behrendtz; E Forestier; M Perkkiö; S Söderhäll; G Lönnerholm; A-C Syvänen
Journal:  Leukemia       Date:  2011-12-16       Impact factor: 11.528

10.  Stabilization of β-catenin upon B-cell receptor signaling promotes NF-kB target genes transcription in mantle cell lymphoma.

Authors:  Gregory Lazarian; Chloe Friedrich; Anne Quinquenel; Julie Tran; Souhail Ouriemmi; Elisabetta Dondi; Antoine Martin; Imane Mihoub; David Chiron; Céline Bellanger; Carole Fleury; Pascal Gélébart; Emmet McCormack; Dominique Ledoux; Catherine Thieblemont; Jacek Marzec; John G Gribben; Florence Cymbalista; Nadine Varin-Blank; Laura Gardano; Fanny Baran-Marszak
Journal:  Oncogene       Date:  2020-02-07       Impact factor: 8.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.